These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21339735)

  • 1. TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells.
    Anania MC; Sensi M; Radaelli E; Miranda C; Vizioli MG; Pagliardini S; Favini E; Cleris L; Supino R; Formelli F; Borrello MG; Pierotti MA; Greco A
    Oncogene; 2011 Jul; 30(27):3011-23. PubMed ID: 21339735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFBP7: an oncosuppressor gene in thyroid carcinogenesis.
    Vizioli MG; Sensi M; Miranda C; Cleris L; Formelli F; Anania MC; Pierotti MA; Greco A
    Oncogene; 2010 Jul; 29(26):3835-44. PubMed ID: 20440262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer.
    Hu S; Liu D; Tufano RP; Carson KA; Rosenbaum E; Cohen Y; Holt EH; Kiseljak-Vassiliades K; Rhoden KJ; Tolaney S; Condouris S; Tallini G; Westra WH; Umbricht CB; Zeiger MA; Califano JA; Vasko V; Xing M
    Int J Cancer; 2006 Nov; 119(10):2322-9. PubMed ID: 16858683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma.
    Mazzoni M; Todoerti K; Agnelli L; Minna E; Pagliardini S; Di Marco T; Borrello MG; Neri A; Greco A
    Cancer Cell Int; 2022 Dec; 22(1):400. PubMed ID: 36503426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
    Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
    Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
    Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
    Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
    Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H
    Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ad-TIMP3 on biologic behavior of choriocarcinoma cells in vitro.
    Chen Y; Qian H; Zhang Y; Ma Y; Lin C; Xiang Y
    J Reprod Med; 2008 Aug; 53(8):608-14. PubMed ID: 18773626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
    Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
    Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
    Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
    J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
    Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM
    Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
    Castellone MD; Celetti A; Guarino V; Cirafici AM; Basolo F; Giannini R; Medico E; Kruhoffer M; Orntoft TF; Curcio F; Fusco A; Melillo RM; Santoro M
    Oncogene; 2004 Mar; 23(12):2188-96. PubMed ID: 14981541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma.
    Diao Y; Fu H; Wang Q
    Am J Ther; 2017 May; 24(3):e317-e328. PubMed ID: 27077469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration.
    Das AM; Seynhaeve AL; Rens JA; Vermeulen CE; Koning GA; Eggermont AM; Ten Hagen TL
    Angiogenesis; 2014 Jan; 17(1):163-77. PubMed ID: 24221409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology of differentiated thyroid cancer.
    Greco A; Borrello MG; Miranda C; Degl'Innocenti D; Pierotti MA
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):440-53. PubMed ID: 19910897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
    Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
    J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.